Literature DB >> 23677730

The atrial fibrillation in Turkey: Epidemiologic Registry (AFTER).

Faruk Ertas1, Nihan Kahya Eren, Hasan Kaya, Alpay Aribas, Goksel Acar, Mehmet Kanadasi, Selcuk Gedik, Mustafa Oylumlu, Murat Yuksel, Mehmet Siddik Ulgen.   

Abstract

BACKGROUND: AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry) is a prospective, multicenter study designed with the aim of describing the prevalence and epidemiology of AF practice in Turkey. This study aims to evaluate stroke risk in non-valvular atrial fibrillation (AF) and anticoagulant drug utilization within conformity to AF guidelines.
METHODS: Patients were recruited in 17 referral hospitals reflecting all the population of 7 geographical regions of Turkey. 2242 consecutive patients who had been admitted with AF on ECG were included in the study. 1745 of these patients, who had non-valvular AF, were included in the statistical evaluation. Stroke risk was evaluated with the CHA2DS2-VASc score.
RESULTS: The average age of participants was determined to be 69.2 ± 11.5 years (56% female). Persistent-permanent AF was found to be the most common type of non-valvular AF (78%). The most common comorbid disorder was hypertension (73%). It was found that oral anticoagulant therapy was used by 40% of all patients, 37% of whom had effective INR (2.0-3.0). Upon multivariate analysis, age was found to be the only independent predictor of stroke among the variables' effects on thromboembolic events that created CHA2DS2-VASc abbreviations (OR 1.026, p < 0.001).
CONCLUSIONS: These results suggest that stroke risk scores should be thoroughly heeded based on guidelines, and that anticoagulation must be applied according to their guidance.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677730     DOI: 10.5603/CJ.a2013.0055

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  9 in total

1.  Poor adherence to anticoagulation guidelines in patients with non-valvular atrial fibrillation treated in a tertiary cardiology unit.

Authors:  Guan Sen Kew; Mabel Tan; Toon Wei Lim
Journal:  Heart Asia       Date:  2015-04-21

2.  Potential Causes and Implications of Low Target Therapeutic Ratio in Warfarin-Treated Patients for Thrombosis Prophylaxis: A Single-Center Experience.

Authors:  Halil Atas; Ahmet Anıl Sahin; Dilek Barutçu Atas; Murat Sunbul; Alper Kepez; Mehmet Agirbasli
Journal:  Clin Appl Thromb Hemost       Date:  2017-03-01       Impact factor: 2.389

3.  Analysis of geographical variations in the epidemiology and management of non-valvular atrial fibrillation: results from the RAMSES registry.

Authors:  Volkan Doğan; Özcan Başaran; Murat Biteker; Fatma Özpamuk Karadeniz; Ahmet İlker Tekkesin; Yasin Çakıllı; Ceyhan Türkkan; Mehmet Hamidi; Vahit Demir; Mustafa Ozan Gürsoy; Müjgan Tek Öztürk; Gökhan Aksan; Sabri Seyis; Mehmet Ballı; Mehmet Hayri Alıcı; Serdar Bozyel; Cevat Kırma
Journal:  Anatol J Cardiol       Date:  2017-08-11       Impact factor: 1.596

4.  Impaired quality of life in patients with intermittent atrial fibrillation.

Authors:  Cem Nazlı; Nihan Kahya Eren; Selcen Yakar Tülüce; İdil Gökçen Koçağra Yağız; Barış Kılıçaslan; Uğur Kocabaş
Journal:  Anatol J Cardiol       Date:  2015-07-13       Impact factor: 1.596

5.  Inappropriate combination of warfarin and aspirin.

Authors:  Burak Turan; Hakan Demir; Ayhan Mutlu; Tolga Daşlı; Ayhan Erkol; İsmail Erden
Journal:  Anatol J Cardiol       Date:  2015-04-24       Impact factor: 1.596

6.  Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in TURKEY: inferences from GARFIELD-AF registry.

Authors:  Begüm Sayın; Sercan Okutucu; Mehmet Birhan Yılmaz; Kurtuluş Özdemir; Ali Aydınlar; Durmuş Yıldıray Şahin; Armağan Altun; Sadık Açıkel; Ertuğrul Okuyan; Murat Sucu; Zeki Öngen; Murat Kazim Ersanlı; Özcan Yılmaz; Mesut Demir; Hasan Pekdemir; Ramazan Topsakal; Mehmet Levent Şahiner; Dursun Aras; Ali Oto
Journal:  Anatol J Cardiol       Date:  2019-04       Impact factor: 1.596

7.  Oral Anticoagulant Use and Long-Term Follow-Up Results in Patients with Non-valvular Atrial Fibrillation in Turkey AFTER-2 Study.

Authors:  Tuncay Güzel; Adem Aktan; Raif Kılıç; Bayram Arslan; Baran Arık; Merve Yentür; Halil Yıldız; Lokman Argun; Kamran İldırımlı; Bünyamin Yıldırım; Muhammed Demir; Mehmet Özbek; Faruk Ertaş
Journal:  Anatol J Cardiol       Date:  2022-07       Impact factor: 1.475

8.  Understanding the Burden of Atrial Fibrillation and Importance of Screening: A Global Perspective and Recommendations for Turkey.

Authors:  Dursun Aras; Erdem Birgül; Bülent Görenek; Erdem Gürkaş; Atilla Özcan Özdemir; Mehmet Akif Topçuoğlu; Erdinç Yavuz; Mehdi Zoghi
Journal:  Anatol J Cardiol       Date:  2022-09       Impact factor: 1.475

Review 9.  Vagal denervation in atrial fibrillation ablation: A comprehensive review.

Authors:  Tolga Aksu; Tümer Erdem Güler; Ferit Onur Mutluer; Mehmet Ali Oto
Journal:  Anatol J Cardiol       Date:  2017-07-25       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.